Tuesday, December 22, 2009
Cell Medica receives second grant for development of adenovirus infection therapy (News-Medical-Net)
Cell Medica, a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has announced that is has appointed four key staff to drive forwards the Companyâs activities in the commercialisation of cell therapy treatments.
Return to Mesothelioma Search Blog Home Page mesothelioma
